ArticleJournal of Crohn's & colitis2025

Uncovering the therapeutic potential of anti-tuberculoid agent Isoniazid in a model of microbial-driven Crohn's disease.

Matthew Stephens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.